openPR Logo
Press release

Companion Diagnostics Market accounted USD 9.40 billion-2024 | F. Hoffmann La Roche Diagnostics, QIAGEN , Abbott, Agilent Technologies, Ventana Medical Systems Inc., Myriad Genetics

02-07-2019 02:28 PM CET | Health & Medicine

Press release from: Data Bridge Market Research

Companion Diagnostics Market accounted USD 9.40 billion-2024 |

Companion diagnostics are in-vitro diagnostics that provide information about therapeutic treatment of patients through which they can be benefitted from certain drug dosage according to their diagnosis, allergies and necessity. Here much technological advancement has been made in order to improve this along with the growing requirements for enhanced personalized patient treatment so that complete assurance must be given by the doctors.
Companion Diagnostics Market accounted to USD 9.40 billion in 2024, growing at a CAGR of 19.8% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic year 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Get a free sample report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-companion-diagnostics-market

This companion diagnostics market report aims to consider the developments of companion diagnostics market including its market improvements, developments, positions, and other recent activities.
This report on the companion diagnostics market offers an expounding knowledge on the market fractions like dominating players, drivers, and restraints, production, revenue, consumption, import, and export. It also gives an insight into the most effective development within the organization size, deployment type, and segmentation is comprised throughout this analysis.
Furthermore, the report also covers some key information like strategies used by the major players such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others, to increase their footprints in the market in order to sustain in long run, is included to clear viewpoint of companion diagnostics market.
The companion diagnostics market report uses SWOT analysis to provide knowledge about the market’s strength and weakness and shows all the opportunity threats.

Major Market Competitors:
F. Hoffmann La Roche Diagnostics, QIAGEN , Abbott, Agilent Technologies, Ventana Medical Systems Inc., Myriad Genetics, Leica Biosystems Nussloch GmbH, RESONANCE HEALTH, ARUP Laboratories, Life Technologies, Thermo Fisher Scientific Inc., and bioMerieux SA among others.

Know in and out of the report Speak to our analyst it’s free of cost https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-companion-diagnostics-market

Companion Diagnostics Market Competitive Analysis:
The global companion diagnostics market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes companion diagnostics shares for global, Europe, North America, Asia Pacific, and South America.

Major Market Drivers and Restraints:
• Increasing number of genetic testing
• Growing technological development
• Increase in cost related to technological advancement

Companion Diagnostics Market Segmentation:
On the basis of product and services, global companion diagnostics market is segmented into assay kits and reagents and software & services.
On the basis of technology, global companion diagnostics market is segmented into polymerase chain reaction, immunohistochemistry, next-generation sequencing and in situ hybridization.
On the basis of indication, global companion diagnostics market is segmented into oncology, neurology and infectious diseases whereas; oncology is sub segmented into breast cancer, lung cancer, colorectal cancer, gastric cancer and melanoma.
On the basis of end users global companion diagnostics market is segmented into pharmaceutical and biopharmaceutical companies and reference laboratories.
On the basis of geography, global companion diagnostics market report covers data points for 28 countries across multiple geographies namely North America & South America, Europe, Asia-Pacific, and Middle East & Africa. Some of the major countries covered in this report are U.S., Canada, Germany, France, U.K., Netherlands, Switzerland, Turkey, Russia, China, India, South Korea, Japan, Australia, Singapore, Saudi Arabia, South Africa, and Brazil among others. In 2017, North America is expected to dominate the market.

Get detailed free TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-companion-diagnostics-market

Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analyzed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please Request an Analyst Call or drop down your inquiry.
Demand Side Primary Contributors: Doctors, Surgeons, Medical Consultants, Nurses, Hospital Buyers, Group Purchasing Organizations, Associations, Insurers, Medical Payers, Healthcare Authorities, Universities, Technological Writers, Scientists, Promoters, and Investors among others.

Read Detailed Report @ https://databridgemarketresearch.com/reports/global-companion-diagnostics-market/

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Companion Diagnostics Market accounted USD 9.40 billion-2024 | F. Hoffmann La Roche Diagnostics, QIAGEN , Abbott, Agilent Technologies, Ventana Medical Systems Inc., Myriad Genetics here

News-ID: 1569601 • Views:

More Releases from Data Bridge Market Research

Calcium Market Size, Share, Trends, Opportunities, Key Drivers and Growth Prospe …
Data Bridge Market research has recently released expansive research titled Global Calcium Market  guarantees you will remain better informed than your competition.The report is formulated based on the market type, organization size, availability on-premises, the end-users' organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific and Middle East & Africa. Businesses can accomplish knowledge about complete background analysis of the industry which includes an
Transparent Plastics Market Size, Share, Trends, Key Drivers, Demand, Opportunit …
Global Transparent Plastic Market report puts light on analysis of prime manufacturers, trends, opportunities, marketing strategies analysis, market effect factor analysis and consumer needs by major regions, types, and applications globally. The study offers a comprehensive analysis of the key market dynamics and their latest trends, along with pertinent market segments and sub-segments. The data and information covered in the Transparent Plastic report are obtained from reliable sources such as
Decorative Coatings Market Size, Share, Key Growth Drivers, Trends, Challenges a …
Global Decorative Coatings Market study by Data Bridge Market Research provides details about the market dynamics affecting this market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. The latest market data has been presented in the Decorative Coatings market study on the revenue numbers, product details, and sales of the major firms. In addition to this,
Industrial Tube Market Size, Share, Trends, Key Drivers, Growth, Challenges and …
Global Industrial Tube Market study by Data Bridge Market Research provides details about the market dynamics affecting the Industrial Tube market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. An all-inclusive Industrial Tube market report enables clients to boost revenues from new and existing customer base as well as identify key trends and hidden opportunities, latest

All 5 Releases


More Releases for Companion

Companion Animal Drugs - Key Market Statistics
Companion animals are pets kept primarily for company, entertainment, and safety. Owners of companion animals consider them to be family, friends, and confidants. Dogs, cats, birds, rabbits, horses, goats, gerbils, rats, mice, and amphibians, others are considered as companion animals. Read Report Overview - https://www.transparencymarketresearch.com/companion-animal-specialty-drugs-market.html According to the American Society for the Prevention of Cruelty to Animals (ASPCA) defines companion animal to be domesticated or domestically-bred whose emotional, physical, social, and behavioral
Companion Animal Vaccine – Improving The Health Of Companion Animals In A Cost …
The companion animal vaccines market is expected to witness significant growth during the forecast period due to launch of vaccines for companion animals. For instance, in December 2017, Zoetis Inc. announced the launch of Vanguard CIV H3N2/H3N8, the latest vaccine in the company’s canine influenza virus (CIV) portfolio. The new bivalent vaccine helps protect dogs against the two strains of the virus known to be circulating in the U.S. Moreover, the
Companion Diagnostics Market - Easing of Regulatory Policies to Drive Global Dem …
Companion diagnostics include two types of tests namely tests which are developed along with target drugs and the other developed after the commercialization of drugs. Companion diagnostics combined with targeted therapeutics are being seen as a major breakthrough in the personalized medicine field. Companies operating in the companion diagnostics market are seeking an effective growth strategy in the development of this concept drug-diagnostic interaction as the healthcare sector is shifting
Global Companion Diagnostics Market
The Global Companion Diagnostics (CDx) Market was valued at US$ 1,614.5 million in 2015 and is projected to expand at a CAGR of 12.0% during the forecast period (2016–2024), as highlighted in a new report published by Coherent Market Insights. Development of multiple biomarkers and targeted drug therapy is boosting research and development collaboration among the industry players. This is expected to improve the time to market for companion diagnostic (CDx) test
Global Companion Diagnostics – Growth Companion for Personalized Medicine
Companion Diagnostics: Growth Companion for Personalized Medicine Personalized medicine is the new segment in discussion among healthcare experts around the globe. Also, encouragement from the regulatory bodies such as the FDA and EMEA in erms of providing a defined structure for companion diagnostic development is driving research activities in personalized medicine. Diagnosis at molecular level for each individual is of prime importance to identify the target biomarker before deciding the therapy.
Companion diagnostics Market: Companion diagnostic are used to determine patient …
The few companion diagnostics are already available in the market for specific types of cancer and many are already under clinical development. Companion diagnostics test depends on finding a specific biomarker in the patient and hence biomarker presence or absence determines whether or not the patient will respond to the treatment. This test require a biopsied tissue to access the expression of biomarker protein or mutant or aberrant genes. Companion